Fig. 9
From: ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
Cluster analysis of CpGs within the TSS1500–TSS200 in ELF5 for primary and recurrent tumors from the three groups of women described in Fig. 8. The PR status of the primary tumor is followed by the PR status of the recurrent tumor, and the data shown are for the tumor group not within the primary parentheses; e.g., (PR+)PR− indicates that the data shown are for the PR-negative second tumors from the group of women who had a PR-positive primary and PR-negative recurrence. Blue box indicates CpG sites that were interrogated by pyrosequencing (see Fig. 7). Coordinate 36 values and functional genomic location are shown